Therefore, we obtained CD8 T cells from infected mice at day 7 post-infection, stimulated them in vitro with either OVA or PLP peptides and adoptively transferred these into naïve recipients, followed by induction of EAE with PLP178-191/CFA immunization. The gene discussed is CD8A; the disease is infection.